Detalhe da pesquisa
1.
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.
Am J Respir Crit Care Med
; 2024 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626354
2.
Pulmonary Surfactant Proteins Are Inhibited by Immunoglobulin A Autoantibodies in Severe COVID-19.
Am J Respir Crit Care Med
; 207(1): 38-49, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35926164
3.
Fractional CO2 laser to improve noticeable scars after skin cancer surgery: An appraisal by the patients, laypersons, and experts.
Dermatol Ther
; 34(4): e14999, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34022110
4.
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.
Nat Cancer
; 4(9): 1292-1308, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37525015
5.
Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors.
Med
; 4(2): 113-129.e7, 2023 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36693381
6.
C reactive protein flare predicts response to checkpoint inhibitor treatment in non-small cell lung cancer.
J Immunother Cancer
; 10(3)2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35292517
7.
Vitamin C Deficiency in Blood Samples of COVID-19 Patients.
Antioxidants (Basel)
; 11(8)2022 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36009299
8.
Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade.
Sci Immunol
; 7(75): eabn9644, 2022 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054337
9.
Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.
Nat Cancer
; 4(9): 1395, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37580519